Mason Street Advisors, LLC Enanta Pharmaceuticals Inc Call Options Transaction History
Mason Street Advisors, LLC
- $786 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
113Shares Held
18.8MCall Options Held
5.6KPut Options Held
13.9K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$11.4 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.12MShares$11.4 Million6.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$10.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$9.92 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.35MShares$7.23 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $111M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...